Neurology and Therapy

Scope & Guideline

Advancing Neurological Health Through Open Access Research

Introduction

Explore the comprehensive scope of Neurology and Therapy through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Neurology and Therapy in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2193-8253
PublisherSPRINGER LONDON LTD
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2012 to 2024
AbbreviationNEUROL THER / Neurol. Ther.
Frequency2 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND

Aims and Scopes

The journal "Neurology and Therapy" is dedicated to advancing the understanding and treatment of neurological disorders through innovative research and clinical studies. The journal covers a broad spectrum of topics related to neurology, emphasizing patient-centered approaches, therapeutic interventions, and the integration of novel methodologies in clinical practice.
  1. Neurological Disorders and Treatments:
    The journal focuses on a wide range of neurological conditions including Alzheimer's disease, multiple sclerosis, Parkinson's disease, epilepsy, and migraine, with a commitment to exploring both pharmacological and non-pharmacological treatments.
  2. Patient-Centric Research:
    A significant emphasis is placed on understanding patient experiences, treatment preferences, and quality of life. Research often incorporates qualitative methods to gauge patient perspectives on their conditions and treatments.
  3. Innovative Therapeutic Approaches:
    The journal highlights advancements in treatment modalities, including novel drug therapies, biologics, and emerging technologies such as deep brain stimulation and virtual reality interventions.
  4. Real-World Evidence and Clinical Practice:
    Research published often includes real-world studies and meta-analyses that assess the effectiveness and safety of treatments in diverse patient populations, thereby bridging the gap between clinical trials and everyday clinical practice.
  5. Biomarkers and Diagnostic Tools:
    The journal explores the development and application of biomarkers and diagnostic methods that aid in the early detection and management of neurological disorders, enhancing personalized treatment strategies.
The landscape of research within "Neurology and Therapy" is evolving, with several themes gaining traction in recent years. This section highlights the emerging scopes that reflect current trends and future directions in neurological research.
  1. Real-World Evidence and Patient Outcomes:
    There is a growing trend towards studies that utilize real-world data to assess the effectiveness and safety of treatments, emphasizing the importance of patient outcomes and experiences in clinical decision-making.
  2. Telehealth and Digital Therapeutics:
    The rise of telehealth and digital therapeutic interventions has become a focal point, particularly in the context of the COVID-19 pandemic, as researchers explore their efficacy in managing neurological conditions.
  3. Personalized Medicine and Biomarkers:
    Research focusing on personalized medicine, particularly the use of biomarkers to tailor treatments to individual patient profiles, is increasingly prominent, reflecting advancements in genetic and molecular research.
  4. Multimodal Approaches to Treatment:
    An emerging trend is the exploration of multimodal treatment strategies that combine pharmacological, behavioral, and rehabilitation therapies, aiming for a more holistic approach to patient care.
  5. Neuroinflammation and Neurodegeneration Research:
    There is a notable increase in studies investigating the role of neuroinflammation in various neurological disorders, as researchers seek to uncover new therapeutic targets and mechanisms.

Declining or Waning

While "Neurology and Therapy" continues to thrive in numerous research areas, certain themes have shown a decline in frequency or prominence in recent publications. These waning scopes may reflect shifting research priorities or advancements in alternative therapeutic strategies.
  1. Traditional Pharmacotherapy for Chronic Conditions:
    There is a noticeable reduction in studies focusing solely on traditional pharmacological approaches to chronic neurological conditions, as the field increasingly embraces combination therapies and integrative treatment models.
  2. Basic Science Research:
    Research articles centered on basic science or purely mechanistic studies are becoming less frequent, possibly due to a shift in focus towards clinical applications and real-world effectiveness.
  3. Longitudinal Studies:
    The prevalence of longitudinal studies examining the long-term outcomes of treatments appears to be decreasing, potentially replaced by more immediate efficacy studies or innovative trial designs.
  4. Conventional Rehabilitation Approaches:
    There is a decline in publications focused on conventional rehabilitation methods, as newer technologies and therapeutic approaches (like virtual reality) gain traction in the field.
  5. Epidemiological Studies of Rare Neurological Disorders:
    Research on rare neurological disorders has seen a decrease, possibly due to the challenges in recruiting large cohorts and the increasing focus on more prevalent conditions or conditions with broader impact.

Similar Journals

Ideggyogyaszati Szemle-Clinical Neuroscience

Advancing the Frontiers of Clinical Neuroscience
Publisher: LITERATURA MEDICAISSN: 0019-1442Frequency: 12 issues/year

Ideggyogyaszati Szemle-Clinical Neuroscience, an esteemed publication under the auspices of LITERATURA MEDICA, serves as a pivotal platform in the field of neurology and clinical neuroscience. Established in Hungary, this journal has been committed to advancing the understanding of neurological disorders and treatments since its inception. With its ISSN 0019-1442 and E-ISSN 2498-6208, it provides a unique local perspective alongside valuable contributions to the global discourse in neuroscience. Despite earning a Q4 quartile ranking in both Neurology and Clinical Neurology, the journal remains dedicated to publishing high-quality research that contributes to the scientific community's collective knowledge. Its coverage spans significant converged years from 1954 to 1985 and now continues through 2024, reflecting a rich historical foundation. Recognizing the importance of open access, the journal strives to enhance accessibility, albeit currently lacking a formal open-access model. Researchers, professionals, and students in the field will find in Ideggyogyaszati Szemle a resource vital for keeping abreast of emerging trends and findings in neurological science.

EUROPEAN NEUROLOGY

Pioneering Research for a Healthier Neurological Future
Publisher: KARGERISSN: 0014-3022Frequency: 6 issues/year

European Neurology, published by KARGER, is a distinguished journal in the field of neurology, catering to both clinical and neuroscience specialties. Since its inception in 1897 and continuing through 2024, the journal has been a vital platform for disseminating significant research findings and insights in neurology. With an ISSN of 0014-3022 and E-ISSN of 1421-9913, it ranks in the Q3 quartile in both clinical neurology and general neurology categories, reflecting its commitment to scholarly excellence while holding the 175th rank in clinical medicine and the 93rd in neuroscience, according to Scopus metrics. European Neurology facilitates a deeper understanding of neurological disorders and treatments, appealing to a diverse readership that includes researchers, clinicians, and students alike. Despite not currently offering open access, the journal’s rigorous peer-review process ensures that only high-quality research reaches its audience, making it an essential resource for those looking to stay informed in the rapidly evolving field of neurology.

PARKINSONISM & RELATED DISORDERS

Exploring breakthroughs in neurodegeneration.
Publisher: ELSEVIER SCI LTDISSN: 1353-8020Frequency: 12 issues/year

PARKINSONISM & RELATED DISORDERS, published by Elsevier Science Ltd, is a prominent peer-reviewed journal dedicated to advancing the understanding of Parkinson's disease and related neurodegenerative disorders. With an impact factor placing it in the Q2 category across multiple fields including Geriatrics and Gerontology and Neurology for 2023, this journal serves as a crucial platform for researchers, healthcare professionals, and students alike. Covering an array of topics from clinical trials to innovative therapeutic strategies, it aims to disseminate valuable insights that can improve patient care and outcomes. While it remains a subscription-based journal, its relevance is underscored by its consistent rankings in Scopus, where it ranks 105th in Clinical Neurology and 35th in Geriatrics and Gerontology. Authored by top scholars in the field, PARKINSONISM & RELATED DISORDERS continues to contribute significantly to the body of knowledge surrounding these debilitating conditions, facilitating the exchange of cutting-edge research and fostering collaboration within the scientific community.

Aktualnosci Neurologiczne

Empowering Neurology Through Open Access
Publisher: MEDICAL COMMUNICATIONSISSN: 1641-9227Frequency: 4 issues/year

Aktualnosci Neurologiczne is a renowned open-access journal dedicated to the field of neurology, published by Medical Communications. As a crucial platform for the dissemination of neurological research, it has been operational since 2005, fostering an inclusive environment for scientific discourse and innovation. With an ISSN of 1641-9227, the journal aims to bridge the gap between clinical practice and research, offering a diverse range of articles that cover the latest developments in neurological science. Although its coverage in Scopus was discontinued after 2017, the journal continues to maintain a robust archive of scholarly articles that contribute to understanding neurological disorders. Researchers, healthcare professionals, and students interested in the latest trends and studies in neurology will find Aktualnosci Neurologiczne an invaluable resource, providing insights that drive advancements in the field. The journal operates from its address in Warsaw, Poland, and invites contributions from the global research community to enrich its content and impact.

CURRENT OPINION IN NEUROLOGY

Exploring the Frontiers of Neurology.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1350-7540Frequency: 6 issues/year

CURRENT OPINION IN NEUROLOGY is a premier academic journal dedicated to providing insightful overviews and critical analyses across all areas of neurology and clinical neurology. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an impressive impact factor, highlighting its influence and relevance in the field—positioning it in the Q1 category for both neurology and clinical neurology as of 2023. With its comprehensive coverage, the journal serves as a vital resource for researchers, healthcare professionals, and students aiming to stay abreast of the latest developments, trends, and breakthroughs in neurological science and practice. Though not open access, articles are available via institutional subscriptions or individual purchase, ensuring that vital research remains accessible to a wide audience. Covering research from its inception in 1993 to ongoing studies in 2024, CURRENT OPINION IN NEUROLOGY stands out as an essential platform for disseminating knowledge and fostering dialogue within the dynamic and evolving landscape of neurology.

Journal of Movement Disorders

Advancing knowledge in movement disorders.
Publisher: KOREAN MOVEMENT DISORDERS SOCISSN: 2005-940XFrequency: 3 issues/year

The Journal of Movement Disorders, published by the Korean Movement Disorders Society, is a premier open access journal dedicated to advancing the field of neurology with a specific focus on movement disorders. Established in 2008 and indexed with ISSN 2005-940X and E-ISSN 2093-4939, this journal plays a vital role in disseminating high-quality research and clinical insights to a global audience. With an impressive Q2 ranking in both Neurology and Clinical Neurology categories for 2023, the journal continues to feature innovative research articles that contribute to better understanding and management of various movement disorders. Ranked 104th out of 400 in Clinical Neurology and 54th out of 192 in Neuroscience, the Journal of Movement Disorders offers an essential platform for researchers, healthcare professionals, and students alike, fostering collaboration and knowledge exchange in a rapidly evolving field.

Degenerative Neurological and Neuromuscular Disease

Fostering collaboration for a healthier nervous system.
Publisher: DOVE MEDICAL PRESS LTDISSN: Frequency: 1 issue/year

Degenerative Neurological and Neuromuscular Disease is a distinguished academic journal published by DOVE MEDICAL PRESS LTD, focusing on the latest advancements in the field of neurology and neuromuscular disorders. With a commitment to disseminating high-quality research, the journal aims to provide a critical platform for researchers, healthcare professionals, and students to share and engage with groundbreaking studies that advance our understanding of degenerative conditions affecting the nervous system. Although the journal's impact factor and h-index are currently not available, its open access model ensures that the valuable findings published within are accessible to a global audience, thereby fostering collaboration and innovation in neurological health. The journal's address is PO BOX 300-008, Albany, Auckland 0752, New Zealand, reflecting its international relevance and commitment to advancing the field of neurology. As the understanding of neurodegenerative diseases and neuromuscular challenges continues to evolve, Degenerative Neurological and Neuromuscular Disease serves as an essential resource for anyone dedicated to improving patient outcomes and advancing scientific knowledge.

RESTORATIVE NEUROLOGY AND NEUROSCIENCE

Exploring Therapeutic Frontiers: Where Neurology Meets Neuroscience
Publisher: IOS PRESSISSN: 0922-6028Frequency: 6 issues/year

RESTORATIVE NEUROLOGY AND NEUROSCIENCE, published by IOS PRESS, is a premier journal dedicated to advancing the fields of neurology and neuroscience. Since its inception in 1989, this journal has played a crucial role in disseminating cutting-edge research findings and innovative therapeutic approaches that aim to restore neurological function and improve patient outcomes. With a focus on developmental neuroscience and clinical neurology, the journal holds a 2023 Scopus ranking of #129 out of 400 in clinical neurology, and #15 out of 37 in developmental neuroscience, reflecting its significant influence in these domains. Although it operates on a non-open access model, RESTORATIVE NEUROLOGY AND NEUROSCIENCE offers valuable insights for researchers, healthcare professionals, and students seeking to deepen their understanding of neural restoration mechanisms and therapeutic strategies. Located in Amsterdam, Netherlands, the journal continues to foster scholarly dialogue and innovation, contributing to the global advancement of neuroscience and neurology.

Clinical Parkinsonism & Related Disorders

Unlocking the mysteries of Parkinson's and related conditions.
Publisher: ELSEVIERISSN: Frequency: 2 issues/year

Clinical Parkinsonism & Related Disorders is a prominent open-access journal published by Elsevier, focused on advancing the understanding and treatment of Parkinson's disease and related neurological conditions. Since its inception in 2019, this journal has aimed to provide a platform for high-quality research, review articles, and clinical studies dedicated to elucidating the complexities of Parkinsonism and its comorbidities. With an E-ISSN of 2590-1125, it has swiftly established its role in the field of clinical neurology, currently ranked in the Q3 quartile for clinical neurology and Q4 for cellular and molecular neuroscience. While its Scopus rankings reflect a competitive landscape, occupying the 241st position in clinical neurology and the 83rd in neuroscience, the journal remains committed to fostering scholarly dialogue and supporting innovative research. Researchers, clinicians, and students will find valuable insights within its pages, contributing to ongoing discourse and the pursuit of effective therapeutic strategies. Access to all articles has been made available since 2019, emphasizing the journal's mission to disseminate knowledge widely and enhance accessibility in the scientific community.

NEUROMUSCULAR DISORDERS

Innovative insights into neuromuscular disorders.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0960-8966Frequency: 12 issues/year

NEUROMUSCULAR DISORDERS is a premier academic journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest research and developments in the fields of neurology, genetics, and pediatric health. With an ISSN of 0960-8966 and an E-ISSN of 1873-2364, this journal has established a significant presence since its inception in 1991, and it continues to contribute to the scientific community with its impactful findings and reviews. The journal boasts a commendable impact factor, reflected in its placement in the Q2 category for Clinical Genetics and Neurology, as well as its positioning in the top tier Q1 for Pediatrics, Perinatology and Child Health according to the latest quartile assessments. With Scopus rankings such as Rank #71/330 in Pediatrics and Rank #51/99 in Clinical Genetics, NEUROMUSCULAR DISORDERS is recognized for its contribution to advancing knowledge in neuromuscular diseases. The journal is essential for researchers, clinicians, and students interested in the intricate relationship between genetics and neurological disorders, providing valuable insights that drive innovation and improve patient care.